ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 259 filers reported holding ACCELERON PHARMA INC in Q1 2021. The put-call ratio across all filers is 1.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $6,813,000 | -76.8% | 39,589 | -83.1% | 0.40% | -76.2% |
| Q2 2021 | $29,319,000 | +21.1% | 233,638 | +30.9% | 1.69% | +16.1% |
| Q1 2021 | $24,212,000 | +415.8% | 178,538 | +386.6% | 1.46% | +421.9% |
| Q4 2020 | $4,694,000 | -29.9% | 36,688 | -38.4% | 0.28% | -43.9% |
| Q3 2020 | $6,700,000 | -67.6% | 59,546 | -72.6% | 0.50% | -61.9% |
| Q2 2020 | $20,710,000 | +39.5% | 217,390 | +31.6% | 1.31% | -4.9% |
| Q1 2020 | $14,843,000 | +90.4% | 165,160 | +12.3% | 1.37% | +144.3% |
| Q4 2019 | $7,796,000 | -51.7% | 147,032 | -64.0% | 0.56% | -61.5% |
| Q3 2019 | $16,130,000 | +62.9% | 408,262 | +69.4% | 1.46% | +60.2% |
| Q2 2019 | $9,902,000 | – | 241,043 | – | 0.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |